{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:25:42Z","timestamp":1790778342324,"version":"4.1.0"},"reference-count":133,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.semnephrol.2012.12.017","type":"journal-article","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T15:40:13Z","timestamp":1362584413000},"page":"169-179","source":"Crossref","is-referenced-by-count":57,"title":["Chronic Kidney Disease: Mineral and Bone Disorder in Children"],"prefix":"10.1016","volume":"33","author":[{"given":"Katherine","family":"Wesseling-Perry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro B.","family":"Salusky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2012.12.017_bib1","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib2","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib3","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1172\/JCI111365","article-title":"Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency","volume":"73","author":"Portale","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib5","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2009-1576","article-title":"The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease","volume":"95","author":"Bacchetta","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ki.2010.107","article-title":"Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease","volume":"78","author":"van Husen","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2215\/CJN.05940611","article-title":"Early skeletal and biochemical alterations in pediatric chronic kidney disease","volume":"7","author":"Wesseling-Perry","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib8","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/jc.2006-0021","article-title":"Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men","volume":"91","author":"Antoniucci","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib9","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1210\/jc.2008-0326","article-title":"Relationship between plasma FGF-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis","volume":"94","author":"Wesseling-Perry","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib10","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bone.2009.08.008","article-title":"Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease","volume":"45","author":"Pereira","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib11","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/ki.2010.168","article-title":"Dysregulation of renal vitamin D metabolism in the uremic rat","volume":"78","author":"Helvig","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib14","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1677\/JOE-07-0267","article-title":"Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells","volume":"195","author":"Krajisnik","year":"2007","journal-title":"J Endocrinol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib16","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI112714","article-title":"Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat","volume":"78","author":"Silver","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib17","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1073\/pnas.82.12.4270","article-title":"Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells","volume":"82","author":"Silver","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib18","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/ki.1973.40","article-title":"Study of intestinal absorption of calcium in patients with renal failure","volume":"3","author":"Coburn","year":"1973","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib19","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/ki.1987.295","article-title":"Vitamin D and the kidney","volume":"32","author":"Holick","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(82)90214-8","article-title":"Increased skin pigment reduces the capacity of skin to synthesise vitamin D3","volume":"1","author":"Clemens","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib21","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/sj.ki.5000394","article-title":"25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells","volume":"70","author":"Ritter","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000098561","article-title":"Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease","volume":"27","author":"Zisman","year":"2007","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4158\/EP.14.1.10","article-title":"Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study","volume":"14","author":"Chandra","year":"2008","journal-title":"Endocr Pract"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib24","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s00467-011-2071-y","article-title":"Can vitamin D slow down the progression of chronic kidney disease?","volume":"27","author":"Shroff","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib25","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1172\/JCI106517","article-title":"On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog","volume":"50","author":"Slatopolsky","year":"1971","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib26","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1210\/jcem-61-4-601","article-title":"On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency","volume":"61","author":"Llach","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1681\/ASN.V133693","article-title":"Regulation of arachidonic acid production by intracellular calcium in parathyroid cells: effect of extracellular phosphate","volume":"13","author":"Almaden","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib28","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s004670000355","article-title":"Molecular mechanisms of secondary hyperparathyroidism","volume":"14","author":"Silver","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid","volume":"366","author":"Brown","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib30","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1210\/jc.84.11.4287","article-title":"A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure","volume":"84","author":"John","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib31","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1210\/en.137.9.3842","article-title":"Expression of a calcium-sensing receptor in a human medullary thyroid carcinoma cell line and its contribution to calcitonin secretion","volume":"137","author":"Freichel","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib32","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2214\/ajr.115.3.547","article-title":"Epiphyseal displacement after metaphyseal fracture in renal osteodystrophy","volume":"115","author":"Kirkwood","year":"1972","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1385\/EP:14:1:61","article-title":"Decreased expression of calcium receptor in parathyroid tissue in patients with hyperparathyroidism secondary to chronic renal failure","volume":"14","author":"Martin-Salvago","year":"2003","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib34","doi-asserted-by":"crossref","first-page":"30337","DOI":"10.1074\/jbc.M201804200","article-title":"Human calcium-sensing receptor gene","volume":"277","author":"Canaff","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib35","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1073\/pnas.94.18.9831","article-title":"Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia","volume":"94","author":"Li","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib36","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1006\/bbrc.1995.2048","article-title":"Loss of calcium responsiveness in cultured bovine parathyroid cells is associated with decreased calcium receptor expression","volume":"212","author":"Brown","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib37","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1172\/JCI119851","article-title":"The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency","volume":"100","author":"Wada","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib38","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/S0272-6386(05)01244-8","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease","volume":"46","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib39","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.1988.96","article-title":"Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD","volume":"33","author":"Salusky","year":"1988","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib40","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1677\/joe.0.0640573","article-title":"A comparison of the effects of the calcitonins, steroid hormones and thyroid hormones on the response of bone to parathyroid hormone in tissue culture","volume":"64","author":"Atkins","year":"1975","journal-title":"J Endocrinol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/8756-3282(93)90162-4","article-title":"In situ localization of PTH\/PTHrP receptor mRNA in the bone of fetal and young rats","volume":"14","author":"Lee","year":"1993","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib42","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wnt\/beta-catenin signaling is an early event in the progression of renal osteodystrophy","volume":"27","author":"Sabbagh","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/ki.1990.187","article-title":"Renal bone disease 1990: an unmet challenge for the nephrologist","volume":"38","author":"Malluche","year":"1990","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib44","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and Dickkopf-1 in renal osteodystrophy","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib45","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2215\/CJN.05940611","article-title":"Early skeletal and biochemical alterations in pediatric chronic kidney disease","volume":"7","author":"Wesseling-Perry","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib46","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1523-1755.2003.00727.x","article-title":"Severe bone disease and low bone mineral density after juvenile renal failure","volume":"63","author":"Groothoff","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib47","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","article-title":"Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure","volume":"310","author":"Hamdy","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib48","doi-asserted-by":"crossref","first-page":"432","DOI":"10.5414\/CNP62432","article-title":"High prevalence of low bone mineral density in pre-dialysis chronic kidney disease patients: bone histomorphometric analysis","volume":"62","author":"Lobao","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib49","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ki.1994.380","article-title":"Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy","volume":"46","author":"Goodman","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib50","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0022-3476(86)81064-2","article-title":"Effects of oral calcium carbonate on control of serum phosphorus and changes in plasma aluminum levels after discontinuation of aluminum-containing gels in children receiving dialysis","volume":"108","author":"Salusky","year":"1986","journal-title":"J Pediatr"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib51","first-page":"56","article-title":"Renal osteodystrophy","volume":"6","author":"Sherrard","year":"1986","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib52","doi-asserted-by":"crossref","first-page":"910","DOI":"10.7326\/0003-4819-98-6-910","article-title":"Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition","volume":"98","author":"Ott","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib53","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","article-title":"Arterial calcifications and bone histomorphometry in end-stage renal disease","volume":"15","author":"London","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib54","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1523-1755.1998.00724.x","article-title":"Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD","volume":"53","author":"Kuizon","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib55","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000057384","article-title":"Intermittent calcitriol therapy and growth in children with chronic renal failure","volume":"24","author":"Kuizon","year":"1998","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib56","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ki.2010.352","article-title":"Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism","volume":"79","author":"Wesseling-Perry","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib57","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ki.1994.31","article-title":"Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD\/CCPD","volume":"45","author":"Salusky","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib58","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.bone.2004.08.004","article-title":"Three children with lower limb fractures and a mineralization defect: a novel bone fragility disorder?","volume":"35","author":"Munns","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib59","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23","volume":"26","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib60","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ki.2010.352","article-title":"Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism","volume":"79","author":"Wesseling-Perry","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib61","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1046\/j.1523-1755.2003.00915.x","article-title":"Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis","volume":"63","author":"Salusky","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib62","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1681\/ASN.2004100885","article-title":"Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols","volume":"16","author":"Salusky","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib63","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00774-005-0630-7","article-title":"Determinants of peak bone mineral density and bone area in young women","volume":"23","author":"Ho","year":"2005","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib64","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00467-007-0527-x","article-title":"Growth hormone axis in chronic kidney disease","volume":"23","author":"Mahesh","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib65","series-title":"Textbook of medical physiology","first-page":"918","article-title":"Pituitary hormones and their control by the hypothalamus","author":"Guyton","year":"2006"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib66","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/BF00858645","article-title":"Disturbance of growth hormone\u2013insulin-like growth factor axis in uraemia","volume":"4","author":"Tonshoff","year":"1990","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib67","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1681\/ASN.2010020192","article-title":"Growth in very young children undergoing chronic peritoneal dialysis","volume":"22","author":"Rees","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib68","series-title":"2008 Annual Report","year":"2008"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib69","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/j.1523-1755.2005.00339.x","article-title":"Parathyroid hormone and growth in children with chronic renal failure","volume":"67","author":"Waller","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib70","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00467-003-1091-7","article-title":"Growth in children with chronic renal failure on intermittent versus daily calcitriol","volume":"18","author":"Schmitt","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib71","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/ki.2010.316","article-title":"The bone and mineral disorder of children undergoing chronic peritoneal dialysis","volume":"78","author":"Borzych","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib72","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1210\/jc.82.4.1007","article-title":"Reduced concentration of serum growth hormone (GH)-binding protein in children with chronic renal failure: correlation with GH insensitivity","volume":"82","author":"Tonshoff","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib73","first-page":"S106","article-title":"Derangements of the somatotropic hormone axis in chronic renal failure","volume":"58","author":"Tonshoff","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib74","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1210\/jc.83.5.1654","article-title":"The insulin-like growth factor axis and growth in children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group","volume":"83","author":"Powell","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib75","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ki.1990.293","article-title":"Soft tissue calcification in pediatric patients with end-stage renal disease","volume":"38","author":"Milliner","year":"1990","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib76","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib77","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.CIR.0000020222.63035.C0","article-title":"Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure","volume":"106","author":"Oh","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib78","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1681\/ASN.2004110932","article-title":"Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation","volume":"16","author":"Litwin","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib79","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.2002.00472.x","article-title":"Cardiovascular disease in pediatric chronic dialysis patients","volume":"62","author":"Chavers","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib80","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.108.783738","article-title":"Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis","volume":"118","author":"Shroff","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib81","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1681\/ASN.2009060640","article-title":"Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification","volume":"21","author":"Shroff","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib82","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1053\/j.ajkd.2004.07.022","article-title":"Coronary artery calcification in patients with CRF not undergoing dialysis","volume":"44","author":"Russo","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib83","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","article-title":"Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation","volume":"89","author":"Ducy","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib84","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1046\/j.1523-1755.2003.00820.x","article-title":"Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels","volume":"63","author":"Moe","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib85","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib86","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1053\/ajkd.2001.24533","article-title":"Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells","volume":"37","author":"Ahmed","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib87","doi-asserted-by":"crossref","first-page":"20E","DOI":"10.1016\/S0002-9149(01)01718-0","article-title":"Insights into the mechanism of vascular calcification","volume":"88","author":"Bostrom","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib88","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1523-1755.2002.00170.x","article-title":"Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins","volume":"61","author":"Moe","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib89","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1046\/j.1523-1755.2002.00625.x","article-title":"Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells","volume":"62","author":"Chen","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib90","doi-asserted-by":"crossref","first-page":"20789","DOI":"10.1074\/jbc.271.34.20789","article-title":"The serum protein alpha2-HS glycoprotein\/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells","volume":"271","author":"Schinke","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib91","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1046\/j.1538-7836.2003.00023.x","article-title":"Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats","volume":"1","author":"Sweatt","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib92","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI17202","article-title":"The serum protein alpha 2-Heremans-Schmid glycoprotein\/fetuin-A is a systemically acting inhibitor of ectopic calcification","volume":"112","author":"Schafer","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib93","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","article-title":"Klotho deficiency causes vascular calcification in chronic kidney disease","volume":"22","author":"Hu","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib94","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.111.053405","article-title":"Vascular klotho deficiency potentiates the development of human artery calcification and mediates resistance to FGF-23","volume":"125","author":"Lim","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib95","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ndt\/gfn571","article-title":"Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences","volume":"24","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib96","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00467-011-1822-0","article-title":"Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients","volume":"26","author":"Srivaths","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib97","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0022-3476(99)70205-2","article-title":"Growth during maintenance hemodialysis: impact of enhanced nutrition and clearance","volume":"134","author":"Tom","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib98","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1007\/s00467-006-0226-z","article-title":"Intensified and daily hemodialysis in children might improve statural growth","volume":"21","author":"Fischbach","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib99","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00467-006-0048-z","article-title":"Calcium and phosphate balance in adolescents on home nocturnal haemodialysis","volume":"21","author":"Hothi","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib100","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","volume":"68","author":"Block","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib101","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","volume":"71","author":"Block","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib102","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2215\/CJN.03820411","article-title":"Mortality in kidney disease patients treated with phosphate binders: a randomized study","volume":"7","author":"Di Iorio","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib103","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s00467-003-1298-7","article-title":"Sevelamer hydrochloride: an effective phosphate binder in dialyzed children","volume":"18","author":"Mahdavi","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib104","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1046\/j.1523-1755.63.s85.18.x","article-title":"A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients","volume":"85","author":"D'Haese","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib105","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1093\/ndt\/gfh282","article-title":"Reducing high phosphate levels in patients with chronic renal failure undergoing dialysis: a 4-week, dose-finding, open-label study with lanthanum carbonate","volume":"19","author":"Hutchison","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib106","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5414\/CNP62193","article-title":"Efficacy and safety of lanthanum carbonate for reduction of serum phosphorus in patients with chronic renal failure receiving hemodialysis","volume":"62","author":"Finn","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib107","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/ndt\/gfl146","article-title":"Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up","volume":"21","author":"Spasovski","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib108","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1111\/j.1523-1755.2005.00753.x","article-title":"Progressive accumulation of lanthanum in the liver of normal and uremic rats","volume":"68","author":"Slatopolsky","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib109","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib110","doi-asserted-by":"crossref","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","article-title":"PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop","volume":"299","author":"Lavi-Moshayoff","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib111","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2215\/CJN.05420709","article-title":"Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?","volume":"5","author":"Oliveira","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib112","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/ndt\/gfq419","article-title":"Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease","volume":"26","author":"Isakova","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib113","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1093\/ndt\/gfr144","article-title":"Lanthanum carbonate reduces FGF23 in chronic kidney disease stage 3 patients","volume":"26","author":"Gonzalez-Parra","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib114","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib115","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib116","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) study","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib117","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1681\/ASN.2010080894","article-title":"Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality","volume":"22","author":"Wolf","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib118","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib119","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00467-012-2110-3","article-title":"Uric acid and IGF1 as possible determinants of FGF23 metabolism in children with normal renal function","volume":"27","author":"Bacchetta","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib120","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2215\/CJN.04760511","article-title":"Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial","volume":"7","author":"Shroff","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib121","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/s00467-003-1284-0","article-title":"Catch-up growth with normal parathyroid hormone levels in chronic renal failure","volume":"18","author":"Waller","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib122","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1053\/j.ajkd.2004.01.012","article-title":"Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4","volume":"43","author":"Coburn","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 3","key":"10.1016\/j.semnephrol.2012.12.017_bib123","article-title":"Control of parathyroid cell growth by calcimimetics","volume":"18","author":"Wada","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib124","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1523-1755.2005.00517.x","article-title":"First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl","volume":"68","author":"Martin","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib125","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/ndt\/gfh925","article-title":"Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism","volume":"20","author":"Serra","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib126","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/en.140.4.1911","article-title":"Calcium sensing in cultured chondrogenic RCJ3.1C5.18 cells","volume":"140","author":"Chang","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib127","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1515\/JPEM.2011.301","article-title":"Changes in plasma FGF23 in growth hormone deficient children during rhGH therapy","volume":"24","author":"Gardner","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib128","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0022-3476(94)70358-2","article-title":"Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study","volume":"124","author":"Fine","year":"1994","journal-title":"J Pediatr"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib129","first-page":"321","article-title":"Stimulation of growth by recombinant human growth hormone in children undergoing peritoneal or hemodialysis treatment","volume":"10","author":"Schaefer","year":"1994","journal-title":"Adv Perit Dial"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib130","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1681\/ASN.2005030291","article-title":"Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism","volume":"16","author":"Mitsnefes","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib131","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1681\/ASN.2005070779","article-title":"Effect of pravastatin in people with diabetes and chronic kidney disease","volume":"16","author":"Tonelli","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib132","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1111\/j.1600-6143.2005.01105.x","article-title":"Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study","volume":"5","author":"Holdaas","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2012.12.017_bib133","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929512002793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929512002793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T08:15:40Z","timestamp":1644480940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929512002793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":133,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0270929512002793"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2012.12.017","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}